Patchwork of portraits of people living with HIV

LET'S TALK ABOUT INDIVIDUALISING HIV TREATMENT

THEY SAY EVERYTHING IS FINE, BUT IS IT?

An estimated 106,890 people were living with HIV in the UK in 2019. Across the disease care continuum challenges still persist1

In 2019 the UK Government set a goal for England to become one of the first countries to reach HIV elimination by 2030.2

ViiVs MISSION

WE EXIST to make sure no one living with HIV and AIDS is left behind

WE ARE 100% dedicated to addressing the challenges of the HIV epidemic. Our focus is on researching and delivering medicines and solution that make a difference to people living with HIV and AIDs

WE WANT to end the AIDS epidemic

To enable individualised treatment, ViiV Healthcare is proud to offer an innovative portfolio of medicines providing a range of options to answer the diverse needs of people living with HIV.

References:

  1. Terrence Higgins Trust. HIV statistics. Available at https://www.nat.org.uk/hiv-and-sexual-health/about-hiv/hiv-statistics. Access date: May 2024
  2. NHS England, What are Intergrated Care Systems? Available at https://www.england.nhs.uk/integratedcare/what-is-integrated-care/. Access date: May 2024
  3. UNAIDS. Understanding Fast-Track: accelerating action to end the AIDS epidemic by 2030. Available at https://www.unaids.org/en/recources/documents/2015/201506_JC2743_Understanding_FastTrack. Access date: May 2024
  4. HIV.gov. HIV Care Continuum. Available at https://www.hiv.gov/federal-response/policies-issues/hiv-aids-care-continuum/. Access date: May 2024
  5. UK GOV. Health Secretary announces goal to end HIV transmissions by 2030. 2019 Available at https://www.gov.uk/government/news/health-secretary-announces-goal-to-end-hiv-transmissions-by-2030. Access date: May 2024

PM-GB-HVX-WCNT-240001 | May 2024

Adverse event reporting

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellowcard in the Google Play or Apple App store. Adverse events should also be reported to GlaxoSmithKline on 0800 221441.

If you are from outside the UK, you can report adverse events to GSK/ViiV by selecting your region and market, here.